Oak Street Health, Inc. (NYSE:OSH) COO Geoffrey M. Price Sells 72,500 Shares

Oak Street Health, Inc. (NYSE:OSH) COO Geoffrey M. Price sold 72,500 shares of the company’s stock in a transaction dated Tuesday, October 26th. The stock was sold at an average price of $45.24, for a total value of $3,279,900.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Geoffrey M. Price also recently made the following trade(s):

  • On Tuesday, August 10th, Geoffrey M. Price sold 50,000 shares of Oak Street Health stock. The stock was sold at an average price of $53.09, for a total value of $2,654,500.00.
  • On Thursday, August 5th, Geoffrey M. Price sold 7,893 shares of Oak Street Health stock. The shares were sold at an average price of $65.12, for a total value of $513,992.16.

NYSE:OSH traded down $1.22 during midday trading on Tuesday, hitting $45.05. The stock had a trading volume of 1,008,997 shares, compared to its average volume of 1,483,290. Oak Street Health, Inc. has a one year low of $35.67 and a one year high of $66.31. The company has a market capitalization of $10.85 billion and a price-to-earnings ratio of -35.51. The stock has a 50-day moving average of $46.87 and a 200 day moving average of $55.19. The company has a quick ratio of 3.40, a current ratio of 3.40 and a debt-to-equity ratio of 4.07.

Oak Street Health (NYSE:OSH) last announced its quarterly earnings data on Monday, August 9th. The company reported ($0.44) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.36) by ($0.08). Oak Street Health had a negative return on equity of 88.34% and a negative net margin of 27.56%. The firm had revenue of $353.10 million during the quarter, compared to the consensus estimate of $318.09 million. Oak Street Health’s quarterly revenue was up 64.7% compared to the same quarter last year. On average, sell-side analysts anticipate that Oak Street Health, Inc. will post -1.78 earnings per share for the current fiscal year.

OSH has been the subject of a number of research reports. Canaccord Genuity dropped their price target on Oak Street Health from $67.00 to $61.00 and set a “buy” rating for the company in a research note on Wednesday, August 11th. Jefferies Financial Group initiated coverage on Oak Street Health in a research note on Wednesday, October 20th. They set a “buy” rating and a $50.00 price target for the company. Raymond James dropped their price target on Oak Street Health from $70.00 to $60.00 and set an “outperform” rating for the company in a research note on Thursday, August 12th. SVB Leerink assumed coverage on Oak Street Health in a research report on Monday, September 27th. They set a “market perform” rating and a $51.00 price objective on the stock. Finally, Morgan Stanley decreased their price objective on Oak Street Health from $79.00 to $60.00 and set an “overweight” rating on the stock in a research report on Tuesday, August 31st. Three analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and an average price target of $63.41.

A number of large investors have recently made changes to their positions in the stock. Nelson Van Denburg & Campbell Wealth Management Group LLC grew its stake in Oak Street Health by 1.9% in the second quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC now owns 9,534 shares of the company’s stock worth $558,000 after purchasing an additional 176 shares in the last quarter. DekaBank Deutsche Girozentrale boosted its position in Oak Street Health by 1.7% during the 3rd quarter. DekaBank Deutsche Girozentrale now owns 17,450 shares of the company’s stock valued at $772,000 after acquiring an additional 289 shares in the last quarter. Weiss Multi Strategy Advisers LLC boosted its position in Oak Street Health by 3.7% during the 2nd quarter. Weiss Multi Strategy Advisers LLC now owns 14,064 shares of the company’s stock valued at $824,000 after acquiring an additional 502 shares in the last quarter. Zeke Capital Advisors LLC boosted its position in Oak Street Health by 15.7% during the 2nd quarter. Zeke Capital Advisors LLC now owns 4,668 shares of the company’s stock valued at $273,000 after acquiring an additional 633 shares in the last quarter. Finally, Baird Financial Group Inc. boosted its position in Oak Street Health by 5.2% during the 2nd quarter. Baird Financial Group Inc. now owns 16,410 shares of the company’s stock valued at $961,000 after acquiring an additional 810 shares in the last quarter. 79.41% of the stock is currently owned by institutional investors.

Oak Street Health Company Profile

Oak Street Health, Inc, together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2020, it operated 79 centers in Illinois, Indiana, Michigan, Mississippi, New York, North Carolina, Ohio, Pennsylvania, Rhode Island, Tennessee, and Texas.

Read More: Determine Your Level of Risk Tolerance

Insider Buying and Selling by Quarter for Oak Street Health (NYSE:OSH)

Receive News & Ratings for Oak Street Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oak Street Health and related companies with MarketBeat.com's FREE daily email newsletter.